Chem. J. Chinese Universities ›› 2015, Vol. 36 ›› Issue (10): 1880.doi: 10.7503/cjcu20150344

• Analytical Chemistry • Previous Articles     Next Articles

Preparation of Label-free C-Reactive Protein Immunosensor Based on the Palladium-coordinated Covalent Organic Frameworks(Pd/COF-LZU1) Material

LIU Tingzhi, XIA Jieren, LI Yao, CHEN Wenkai, ZHANG Shuai, LIU Yi, ZHENG Li, YANG Yunhui*()   

  1. College of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming 650500, China
  • Received:2015-04-28 Online:2015-10-10 Published:2015-09-18
  • Contact: YANG Yunhui E-mail:yyhui2002@aliyun.com
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.21465026, 21165023)

Abstract:

A new imine-linked covalent organic framework(COF) material was synthesized using organic monomer via solvothermal methods. Pd(Ⅱ)-coordinated COF, Pd/COF-LZU1, was accordingly synthesized through simple post-treatment at ambient conditions, which showed excellent catalytic activity. Then, a label-free C-reactive protein(CRP) immunosensor was constructed using the Pd/COF-LZUI porous composite material to immobilize anti-CRP on the surface of GCE. When anti-CRP binds with CRP antigen, the formed immuno complex obstruct the electric signal of Fe(CN)64-/3-, which can be used to realize label-free detection of CRP. Electrochemical impedence spectroscopy(EIS) and differential pulse voltammetry(DPV) were employed to characterize the immunosensor. The experimental conditions such as scanning rate, pH value of testing solution, the concentration of anti-CRP and incubation time were also optimized. Under the optimal experimental conditions, the linear range was 5—180 ng/mL, the detection limit was 1.66 ng/mL, with the linear correlation coefficient of 0.992. This immunosensor provides a novel and simple way to detect CRP, and develops the application of the COFs in the electrochemical immunosensor.

Key words: Pd/covalent organic frameworks(COFs), C-Reactive protein(CRP), Immunosensor, Label-free

CLC Number: 

TrendMD: